Dottikon ES : Shareholders Approve all Proposals of the Board of Directors

MEDIA RELEASE Dottikon, July 3, 2015 DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors

Dottikon, Switzerland, July 3, 2015 - The shareholders approved all proposals of the Board of
Directors at the 10th Annual General Meeting of DOTTIKON ES HOLDING AG in Baden. The
78 present shareholders represented 1'166'494 voting rights and therefore 96.4% of the total of
1'210'122 registered shares with voting rights.
The Annual Report, the financial statements 2014/15, and the Group financial statements
2014/15 of DOTTIKON ES HOLDING AG were approved by the Annual General Meeting. The Compensation Report 2014/15 was presented to and taken notice of by the Annual General Meeting. Discharge for the business year 2014/15 was granted to the responsible Board of Direc- tors and Senior Management. Further, the proposal of the Board of Directors to carry forward
the entire retained earnings to new account and to pay no dividend was accepted. The previous Chairman of the Board of Directors Dr. Markus Blocher was confirmed for another one-year term. Dr. Thomas Früh was reelected for a one-year term as Deputy Chairman and Dr. Alfred Scheideg- ger as member of the Board. All three Board members were reelected for a term of one year as members of the Compensation Committee. Dr. Markus Blocher was elected as its Chairman and Dr. Thomas Früh as Deputy Chairman. The proposed maximum amounts of prospective remu- nerations for the entire Board of Directors and Senior Management, respectively, were approved. Peter E. Widmer, lic. iur. and notary, was appointed as independent proxy for the next 11th Annual General Meeting. Deloitte AG, Zurich, was reelected as external auditor for another one-year term.
DOTTIKON ES manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons.
DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development as well as clear and transparent communication
with customers.

Dottikon ES Holding AG

P.O. Box, 5605 Dottikon, Switzerland, Tel [phone], Fax [phone], [e-mail], www.dottikon.com

DOTTIKON ES HOLDING AG is listed at the SIX Swiss Exchange. Symbol: DESN
Security number: 2073900
ISIN: CH0020739006
For further information please contact
Markus Blocher, Ph.D. CEO
Dottikon ES Holding AG Tel [phone]
Fax [phone]
[e-mail]

Dottikon ES Holding AG

P.O. Box, 5605 Dottikon, Switzerland, Tel [phone], Fax [phone], [e-mail], www.dottikon.com